Business Context and Reporting Period
Company: cbdMD, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 20, 2019
Reporting Period: Single event date (September 20, 2019)
Business Context: The registrant is an emerging growth company incorporated in North Carolina. Its common stock trades on the NYSE American under the symbol YCBD. This filing primarily serves to disclose a Regulation FD event regarding an investor presentation related to a securities offering.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing to disclose the availability of an investor presentation rather than a financial statement report.
Material Changes
Securities Offering Disclosure: The Company filed an investor presentation as a free writing prospectus pursuant to Rule 433. This presentation was made available to investors during the offering process for shares of the 8% Series A Cumulative Convertible Preferred Stock. The presentation is incorporated by reference as Exhibit 99.1.
Guidance, Outlook, and Risks
Management Commentary: The filing references an investor presentation but does not contain the text of the presentation itself within this document. Consequently, specific guidance, outlook, or management commentary is not available in this text.
Risks and Contingencies: The filing explicitly states that the information in Item 7.01 and Exhibit 99.1 shall not be deemed filed for purposes of Section 18 of the Securities Act of 1934, nor incorporated by reference in any filing under the Securities Act of 1933, except as expressly set forth by specific reference. No specific risks or contingencies are detailed in the body of this 8-K.
Investor Verification Checklist
- Verify the terms of the 8% Series A Cumulative Convertible Preferred Stock offering by reviewing Exhibit 99.1 (Investor Presentation dated September 20, 2019).
- Confirm the status of the Registration Statement on Form S-3 (Registration No. 333-228773) referenced in the filing.
- Review the preliminary prospectus supplement dated September 20, 2019, for detailed financial data and risk factors not included in this summary.
- Note that the investor presentation is not deemed "filed" under Section 18 of the Securities Act, which may limit liability protections for the information contained therein.